Mark Hollywood
Insider
First SEC filing: Jan. 13, 2026 · Latest: Jan. 13, 2026
Insider at
Insider transactions
0 buys (P)
1 sells (S)
Net: $-138,740
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| July 6, 2026 | ZYME | A | 939 | $22.22 | $20,865 | 133,852 Direct | +0.71% | Acquired | 18.0% (price as of 2026-10-05) |
| Jan. 12, 2026 | ZYME | A | 66,000 | · | · | 66,000 Direct | · | Acquired | (price as of 2026-10-05) |
| Jan. 12, 2026 | ZYME | A | 47,000 | · | · | 47,000 Direct | · | Acquired | (price as of 2026-10-05) |
| Jan. 12, 2026 | ZYME | A | 70,000 | · | · | 70,000 Direct | · | Acquired | (price as of 2026-10-05) |
| Jan. 12, 2026 | ZYME | M | 17,666 | · | · | 35,334 Direct | -33.33% | Disposed | (price as of 2026-10-05) |
| Jan. 12, 2026 | ZYME | S | 6,120 | $22.67 | $138,740 | 132,913 Direct | -4.40% | Disposed | 15.6% (price as of 2026-10-05) |
| Jan. 12, 2026 | ZYME | M | 17,666 | · | · | 139,033 Direct | +14.56% | Acquired | (price as of 2026-10-05) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Jan. 12, 2026 | ZYME | Performance Stock Unit | Common Stock | · | · | 66,000 | Acquired |
| Jan. 12, 2026 | ZYME | Restricted Stock Unit | Common Stock | · | · | 47,000 | Acquired |
| Jan. 12, 2026 | ZYME | Stock Option (Right to Buy) | Common Stock | $23.16 | Jan. 11, 2036 | 70,000 | Acquired |
| Jan. 12, 2026 | ZYME | Restricted Stock Unit | Common Stock | · | · | 17,666 | Disposed |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 10 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Jan. 13, 2026 | ZYME | Common Stock | 121,367 | Direct |
| Jan. 13, 2026 | ZYME | Stock Option (Right to Buy) | 80,000 | Direct |
| Jan. 13, 2026 | ZYME | Stock Option (Right to Buy) | 24,375 | Direct |
| Jan. 13, 2026 | ZYME | Stock Option (Right to Buy) | 30,000 | Direct |
| Jan. 13, 2026 | ZYME | Stock Option (Right to Buy) | 90,000 | Direct |
| Jan. 13, 2026 | ZYME | Stock Option (Right to Buy) | 61,000 | Direct |
| Jan. 13, 2026 | ZYME | Stock Option (Right to Buy) | 90,000 | Direct |
| Jan. 13, 2026 | ZYME | Stock Option (Right to Buy) | 79,000 | Direct |
| Jan. 13, 2026 | ZYME | Restricted Stock Unit | 20,000 | Direct |
| Jan. 13, 2026 | ZYME | Restricted Stock Unit | 53,000 | Direct |